Evidence map›Paper›PMID 39371924›Full record

ArticleFrontiers in endocrinology2024

Case report: Novel germline c.587delA pathogenic variant in familial multiple endocrine neoplasia type 1.

Haotian Huang, Jianwei Li, Kun Zhang, Yu Tang, Min Zhang, Zhen Fan, Tao Wang, Yaoxia Liu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Haotian HuangSchool of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Jianwei LiDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.
Kun ZhangSchool of Biological Sciences and Technology, Chengdu Medical College, Chengdu, China.
Yu TangDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.
Min ZhangDepartment of Geriatric Endocrinology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Zhen FanDepartment of Geriatric Endocrinology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Tao WangDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Yaoxia LiuDepartment of Geriatric Endocrinology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple Endocrine Neoplasia type 1 (

Indexed as

Germ-Line MutationMultiple Endocrine Neoplasia Type 1PedigreeProto-Oncogene ProteinsAdolescentHumansInsulinomaMalePancreatic NeoplasmsMEN1 protein, humanProto-Oncogene ProteinsMEN1 genemeninmultiple endocrine neoplasia type 1pathogenic variantpediatric endocrinology

Identifiers

PMID39371924
PMCPMC11452907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.